Unknown/ LU2010095458 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 42.37 mill.EUR | 0.00% | - |
GlobeNewswire
00:30
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meetin...
GlobeNewswire
09/05
Xtribe, Technology-driven Geolocation-based Commerce Platform, to Go Public on Nasdaq through Propos...
GlobeNewswire
09/05
ECN Capital Reports US $0.00 in Adjusted Net Income per Common Share in Q1-2024 Triad results signif...
GlobeNewswire
09/05
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
09/05
U.S. Energy Corp. Reports Financial and Operating Results for First Quarter 2024
GlobeNewswire
09/05
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
09/05
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
09/05
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Gu...
GlobeNewswire
09/05
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track fo...
GlobeNewswire
09/05
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
09/05
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
GlobeNewswire
09/05
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results